Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-017621
Filing Date
2018-03-29
Accepted
2018-03-28 17:39:26
Documents
5
Period of Report
2018-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv489828_6k.htm 6-K 14521
2 EXHIBIT 99.1 tv489828_ex99-1.htm EX-99.1 20810
3 EXHIBIT 99.2 tv489828_ex99-2.htm EX-99.2 36870
4 GRAPHIC image_001.jpg GRAPHIC 4108
5 GRAPHIC image_002.jpg GRAPHIC 4055
  Complete submission text file 0001144204-18-017621.txt   84823
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35932 | Film No.: 18719974
SIC: 2834 Pharmaceutical Preparations